<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04859868</url>
  </required_header>
  <id_info>
    <org_study_id>20-005763</org_study_id>
    <nct_id>NCT04859868</nct_id>
  </id_info>
  <brief_title>Non-pharmaceutical Motion Sickness Mitigation</brief_title>
  <official_title>Non-pharmaceutical Motion Sickness Mitigation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is evaluate the effect of timing and magnitude on the&#xD;
      administration of our nonpharmaceutical treatment to motion sickness, and to evaluate the&#xD;
      effect of GVR amplitude on functional fitness task performance.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 12, 2021</start_date>
  <completion_date type="Anticipated">March 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Motion Perception</measure>
    <time_frame>During the rotation of the chair, approximately 1 hr</time_frame>
    <description>Motion Perception verbal report using a visual analog scale (1-100) will be recorded during the rotation of the chair (1=feeling no motion perception; 100=feeling the maximum motion perception)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Motion Sickness Questionnaire</measure>
    <time_frame>During the rotation of the chair, approximately 1 hr</time_frame>
    <description>subjective experiences of motion sickness in a scale of 0-10 (0=not at all; 10=most severe)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Galvanic Vestibular Stimulation during the entire session</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be given galvanic vestibular stimulation (GVS), which applies low electrical currents to the vestibular system, during the entire session.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects will be not be given galvanic vestibular stimulation (GVS) during the entire session.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Galvanic Vestibular Stimulation starting from mid-session</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be given galvanic vestibular stimulation (GVS), which applies low electrical currents to the vestibular system, starting from mid-session.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Galvanic Vestibular Stimulation</intervention_name>
    <description>Low electrical currents to the vestibular system.</description>
    <arm_group_label>Galvanic Vestibular Stimulation during the entire session</arm_group_label>
    <arm_group_label>Galvanic Vestibular Stimulation starting from mid-session</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Must be able to consent to participate themselves.&#xD;
&#xD;
          -  Must be 21 to 55 years of age.&#xD;
&#xD;
          -  Must be able to attend in-person sessions at the Mayo Aerospace Medicine and - -&#xD;
             ------&#xD;
&#xD;
          -  Vestibular Research Laboratory in Scottsdale, AZ.&#xD;
&#xD;
          -  No racial ethnic groups will be excluded.&#xD;
&#xD;
          -  Must be fluent speakers of English.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of vestibular disease, migraine, or significant balance disorder.&#xD;
&#xD;
          -  Traumatic brain injury.&#xD;
&#xD;
          -  Recent middle ear infection or recent motion sickness (within 72 hours).&#xD;
&#xD;
          -  History of severe motion sensitivity.&#xD;
&#xD;
          -  Women who are pregnant.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gaurav N Pradhan, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jody Devine</last_name>
      <phone>480-301-6767</phone>
      <email>devine.jody@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 1, 2021</study_first_submitted>
  <study_first_submitted_qc>April 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2021</study_first_posted>
  <last_update_submitted>April 23, 2021</last_update_submitted>
  <last_update_submitted_qc>April 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Gaurav N. Pradhan</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Motion Sickness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

